Annual D&A
$3.54 M
+$1.92 M+118.04%
December 31, 2023
Summary
- As of February 8, 2025, XENE annual depreciation & amortization is $3.54 million, with the most recent change of +$1.92 million (+118.04%) on December 31, 2023.
- During the last 3 years, XENE annual D&A has risen by +$2.90 million (+449.84%).
- XENE annual D&A is now at all-time high.
Performance
XENE Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$669.00 K
+$10.00 K+1.52%
September 30, 2024
Summary
- As of February 8, 2025, XENE quarterly depreciation & amortization is $669.00 thousand, with the most recent change of +$10.00 thousand (+1.52%) on September 30, 2024.
- Over the past year, XENE quarterly D&A has increased by +$10.00 thousand (+1.52%).
- XENE quarterly D&A is now -61.42% below its all-time high of $1.73 million, reached on September 30, 2023.
Performance
XENE Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$2.78 M
-$1.06 M-27.71%
September 30, 2024
Summary
- As of February 8, 2025, XENE TTM depreciation & amortization is $2.78 million, with the most recent change of -$1.06 million (-27.71%) on September 30, 2024.
- Over the past year, XENE TTM D&A has dropped by -$1.06 million (-27.71%).
- XENE TTM D&A is now -27.71% below its all-time high of $3.84 million, reached on June 30, 2024.
Performance
XENE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
XENE Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +118.0% | +1.5% | -27.7% |
| 3 y3 years | +449.8% | +11.1% | +51.9% |
| 5 y5 years | +504.3% | +11.1% | +51.9% |
XENE Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +290.8% | -61.4% | +147.8% | -27.7% | +206.6% |
| 5 y | 5-year | at high | +725.4% | -61.4% | +543.3% | -27.7% | +547.5% |
| alltime | all time | at high | +725.4% | -61.4% | +746.8% | -27.7% | +1487.4% |
Xenon Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $669.00 K(+1.5%) | $2.78 M(-27.7%) |
| Jun 2024 | - | $659.00 K(+10.0%) | $3.84 M(+1.5%) |
| Mar 2024 | - | $599.00 K(-29.6%) | $3.79 M(+6.9%) |
| Dec 2023 | $3.54 M(+118.0%) | $851.00 K(-50.9%) | $3.54 M(+10.5%) |
| Sep 2023 | - | $1.73 M(+188.0%) | $3.21 M(+75.2%) |
| Jun 2023 | - | $602.00 K(+70.1%) | $1.83 M(+14.2%) |
| Mar 2023 | - | $354.00 K(-31.3%) | $1.60 M(-1.4%) |
| Dec 2022 | $1.62 M(+79.2%) | $515.00 K(+43.9%) | $1.62 M(+17.8%) |
| Sep 2022 | - | $358.00 K(-4.5%) | $1.38 M(+12.1%) |
| Jun 2022 | - | $375.00 K(-0.3%) | $1.23 M(+13.3%) |
| Mar 2022 | - | $376.00 K(+39.3%) | $1.09 M(+19.9%) |
| Dec 2021 | $906.00 K(+40.7%) | $270.00 K(+29.2%) | $906.00 K(+8.1%) |
| Sep 2021 | - | $209.00 K(-9.5%) | $838.00 K(+4.8%) |
| Jun 2021 | - | $231.00 K(+17.9%) | $800.00 K(+8.7%) |
| Mar 2021 | - | $196.00 K(-3.0%) | $736.00 K(+14.3%) |
| Dec 2020 | $644.00 K(+50.1%) | $202.00 K(+18.1%) | $644.00 K(+9.5%) |
| Sep 2020 | - | $171.00 K(+2.4%) | $588.00 K(+12.9%) |
| Jun 2020 | - | $167.00 K(+60.6%) | $521.00 K(+14.8%) |
| Mar 2020 | - | $104.00 K(-28.8%) | $454.00 K(+5.8%) |
| Dec 2019 | $429.00 K(-26.8%) | $146.00 K(+40.4%) | $429.00 K(+1.2%) |
| Sep 2019 | - | $104.00 K(+4.0%) | $424.00 K(-8.4%) |
| Jun 2019 | - | $100.00 K(+26.6%) | $463.00 K(-10.1%) |
| Mar 2019 | - | $79.00 K(-44.0%) | $515.00 K(-12.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $586.00 K(-9.7%) | $141.00 K(-1.4%) | $586.00 K(-1.0%) |
| Sep 2018 | - | $143.00 K(-5.9%) | $592.00 K(-4.1%) |
| Jun 2018 | - | $152.00 K(+1.3%) | $617.00 K(-2.7%) |
| Mar 2018 | - | $150.00 K(+2.0%) | $634.00 K(-2.3%) |
| Dec 2017 | $649.00 K(-24.9%) | $147.00 K(-12.5%) | $649.00 K(-2.8%) |
| Sep 2017 | - | $168.00 K(-0.6%) | $668.00 K(+0.1%) |
| Jun 2017 | - | $169.00 K(+2.4%) | $667.00 K(-10.7%) |
| Mar 2017 | - | $165.00 K(-0.6%) | $747.00 K(-13.5%) |
| Dec 2016 | $864.00 K(-16.8%) | $166.00 K(-0.6%) | $864.00 K(-12.0%) |
| Sep 2016 | - | $167.00 K(-32.9%) | $982.00 K(-8.8%) |
| Jun 2016 | - | $249.00 K(-11.7%) | $1.08 M(-3.2%) |
| Mar 2016 | - | $282.00 K(-0.7%) | $1.11 M(+7.2%) |
| Dec 2015 | $1.04 M(+40.7%) | $284.00 K(+8.4%) | $1.04 M(+8.2%) |
| Sep 2015 | - | $262.00 K(-8.1%) | $959.00 K(+9.0%) |
| Jun 2015 | - | $285.00 K(+37.7%) | $880.00 K(+14.3%) |
| Mar 2015 | - | $207.00 K(+1.0%) | $770.00 K(+4.3%) |
| Dec 2014 | $738.00 K(+4.7%) | $205.00 K(+12.0%) | $738.00 K(+38.5%) |
| Sep 2014 | - | $183.00 K(+4.6%) | $533.00 K(+52.3%) |
| Jun 2014 | - | $175.00 K(0.0%) | $350.00 K(+100.0%) |
| Mar 2014 | - | $175.00 K | $175.00 K |
| Dec 2013 | $705.00 K(-10.3%) | - | - |
| Dec 2012 | $786.00 K(-30.6%) | - | - |
| Dec 2011 | $1.13 M | - | - |
FAQ
- What is Xenon Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual D&A year-on-year change?
- What is Xenon Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly D&A year-on-year change?
- What is Xenon Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals TTM D&A year-on-year change?
What is Xenon Pharmaceuticals annual depreciation & amortization?
The current annual D&A of XENE is $3.54 M
What is the all time high annual D&A for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual depreciation & amortization is $3.54 M
What is Xenon Pharmaceuticals annual D&A year-on-year change?
Over the past year, XENE annual depreciation & amortization has changed by +$1.92 M (+118.04%)
What is Xenon Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of XENE is $669.00 K
What is the all time high quarterly D&A for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly depreciation & amortization is $1.73 M
What is Xenon Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, XENE quarterly depreciation & amortization has changed by +$10.00 K (+1.52%)
What is Xenon Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of XENE is $2.78 M
What is the all time high TTM D&A for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high TTM depreciation & amortization is $3.84 M
What is Xenon Pharmaceuticals TTM D&A year-on-year change?
Over the past year, XENE TTM depreciation & amortization has changed by -$1.06 M (-27.71%)